Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 9-12 November 2026

Seven new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended seven medicines for approval at its November 2026 meeting.The committee…, CHMP statistics Key figures from the November 2026 CHMP meeting are represented in the graphic below. © European Medicines Agency , CHMP statistics:…, Positive recommendations on new medicines, Aumseqa International non-proprietary name (INN) aumolertinib Marketing authorisation applicant SFL Pharmaceuticals Deutschland GmbH Therapeutic indication…, Baxfendy INN baxdrostat Marketing authorisation applicant AstraZeneca AB Therap

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.